EWTX Edgewise Therapeutics, Inc.: institutional ownership and insider trading

240 funds reported holding $5.21B of Edgewise Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $5.98M, with 38 new positions and 27 funds selling out; over the last 12 months insiders bought $199K and sold $18.4M on the open market.

EWTX revenue and earnings

Famous investors holding EWTX

Largest institutional holders of EWTX

  1. ORBIMED ADVISORS LLC — $631M
  2. Paradigm Biocapital Advisors LP — $415M
  3. RA CAPITAL MANAGEMENT, L.P. — $341M
  4. BlackRock, Inc. (BLK) — $268M
  5. Jupiter Topco LLC — $247M
  6. FMR LLC — $223M
  7. Novo Holdings A/S — $217M
  8. DRIEHAUS CAPITAL MANAGEMENT LLC — $192M
  9. JANUS HENDERSON GROUP PLC (JHG) — $186M
  10. PERCEPTIVE ADVISORS LLC — $178M

Recent EWTX insider trades

5%+ owners

Who owns the most EWTX stock?

The largest institutional holders of Edgewise Therapeutics, Inc. in the latest 13F filings are ORBIMED ADVISORS LLC ($631M), Paradigm Biocapital Advisors LP ($415M), RA CAPITAL MANAGEMENT, L.P. ($341M).

Are insiders buying or selling EWTX?

Over the last 12 months insiders bought $199K and sold $18.4M of Edgewise Therapeutics, Inc. stock on the open market (SEC Form 4).

Which famous investors own EWTX?

Ken Griffin, D. E. Shaw, Two Sigma.

Which ETFs hold EWTX?

38 ETFs and mutual funds hold it among their top 100 positions, including ANOAX, JAGLX, GOFCX, FBIOX.

All EWTX 13F holders · All EWTX insider trades